ClinicalTrials.govpublic full text
Chronic CED of TPT for Recurrent Malignant Glioma
brain tumor, recurrent, malignant glioma (who grade iii or iv), idh1/idh2 mutation, brain tumors, topotecan, convection-enhanced delivery (ced), glioma, idh mutation, interventional, phase1
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 1009123
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.